{"schema_version":"secwatch.filing_event.v1","accession":"0001642545-24-000016","form_type":"8-K","ticker":null,"cik":"0001642545","company_name":"Shockwave Medical, Inc.","filed_at":"2024-01-29T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.951839+00:00","generated_at":"2026-06-06T15:57:49.473739+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Shockwave Medical names Renee Gaeta CFO, replacing retiring Dan Puckett","bullets":["Renee Gaeta appointed CFO effective Feb 5, 2024; previously CFO at Eko Health and Establishment Labs.","Dan Puckett resigns as CFO, will consult through Feb 2025; receives $20k/month for first 8 months, then $10k/month.","Gaeta's compensation: $500k base salary, 60% target bonus, and $4.5M in RSUs vesting over 4 years.","Gaeta serves on board and audit committee of Candel Therapeutics since Aug 2022."],"urls":{"canonical":"https://secwatch.observer/filing/0001642545-24-000016","json":"https://secwatch.observer/filing/0001642545-24-000016.json","markdown":"https://secwatch.observer/filing/0001642545-24-000016.md","text":"https://secwatch.observer/filing/0001642545-24-000016.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1642545/000164254524000016/0001642545-24-000016-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1642545/000164254524000016/gnw-20240128.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T15:57:49.473739+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"75f1f24613","claim":"Daniel Puckett resigned as Chief Financial Officer at Shockwave Medical, Inc..","evidence_excerpt":"On January 29, 2024, Daniel Puckett resigned as Chief Financial Officer of the Company, effective as of the Effective Date.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1642545/000164254524000016/0001642545-24-000016-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"83114d8100","claim":"Renee Gaeta was appointed as Chief Financial Officer at Shockwave Medical, Inc..","evidence_excerpt":"On January 28, 2024, the board of directors of Shockwave Medical, Inc. (the “Company”) appointed Renee Gaeta as Chief Financial Officer and to act as the Company’s principal financial officer for Securities and Exchange Commission (“SEC”) reporting purposes, effective as of February 5, 2024 (the “Effective Date”).","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1642545/000164254524000016/0001642545-24-000016-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}